| The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas K Shoji, K Oda, S Nakagawa, S Hosokawa, G Nagae, Y Uehara, K Sone, ... British journal of cancer 101 (1), 145-148, 2009 | 167 | 2009 |
| Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary Y Morita, O Wada-Hiraike, T Yano, A Shirane, M Hirano, H Hiraike, ... Reproductive Biology and Endocrinology 10, 1-10, 2012 | 165 | 2012 |
| Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair K Sone, L Piao, M Nakakido, K Ueda, T Jenuwein, Y Nakamura, ... Nature communications 5 (1), 5691, 2014 | 118 | 2014 |
| Genotype-dependent efficacy of a dual PI3K/mTOR inhibitor, NVP-BEZ235, and an mTOR inhibitor, RAD001, in endometrial carcinomas K Shoji, K Oda, T Kashiyama, Y Ikeda, S Nakagawa, K Sone, Y Miyamoto, ... PloS one 7 (5), e37431, 2012 | 96 | 2012 |
| The anti-malarial chloroquine suppresses proliferation and overcomes cisplatin resistance of endometrial cancer cells via autophagy inhibition T Fukuda, K Oda, O Wada-Hiraike, K Sone, K Inaba, Y Ikeda, A Miyasaka, ... Gynecologic oncology 137 (3), 538-545, 2015 | 83 | 2015 |
| Identification of DBC1 as a transcriptional repressor for BRCA1 H Hiraike, O Wada-Hiraike, S Nakagawa, S Koyama, Y Miyamoto, K Sone, ... British journal of cancer 102 (6), 1061-1067, 2010 | 82 | 2010 |
| Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer. T Tsuruga, S Nakagawa, M Watanabe, S Takizawa, Y Matsumoto, ... Oncology research 16 (9), 431-435, 2007 | 81 | 2007 |
| PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer A Miyasaka, K Oda, Y Ikeda, K Sone, T Fukuda, K Inaba, C Makii, ... Gynecologic oncology 138 (1), 174-180, 2015 | 71 | 2015 |
| Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells A Miyasaka, K Oda, Y Ikeda, O Wada-Hiraike, T Kashiyama, A Enomoto, ... BMC cancer 14, 1-10, 2014 | 67 | 2014 |
| Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer S Oki, K Sone, K Oda, R Hamamoto, M Ikemura, D Maeda, M Takeuchi, ... Oncotarget 8 (25), 40402, 2017 | 63 | 2017 |
| Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423 T Kashiyama, K Oda, Y Ikeda, Y Shiose, Y Hirota, K Inaba, C Makii, ... PloS one 9 (2), e87220, 2014 | 55 | 2014 |
| Mutations of the basic amino acid transporter gene associated with cystinuria K Miyamoto, K Katai, S Tatsumi, K Sone, H Segawa, H Yamamoto, ... Biochemical Journal 310 (3), 951-955, 1995 | 55 | 1995 |
| Repression of estrogen receptor β function by putative tumor suppressor DBC1 S Koyama, O Wada-Hiraike, S Nakagawa, M Tanikawa, H Hiraike, ... Biochemical and biophysical research communications 392 (3), 357-362, 2010 | 53 | 2010 |
| Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas Y Uehara, K Oda, Y Ikeda, T Koso, S Tsuji, S Yamamoto, K Asada, K Sone, ... PLoS One 10 (6), e0128066, 2015 | 50 | 2015 |
| Regulation of SIRT1 determines initial step of endometrial receptivity by controlling E-cadherin expression A Shirane, O Wada-Hiraike, M Tanikawa, T Seiki, H Hiraike, Y Miyamoto, ... Biochemical and biophysical research communications 424 (3), 604-610, 2012 | 48 | 2012 |
| The oncogenic polycomb histone methyltransferase EZH2Methylates Lysine 120 on Histone H2B and competes ubiquitination M Kogure, M Takawa, V Saloura, K Sone, L Piao, K Ueda, R Ibrahim, ... Neoplasia 15 (11), 1251-IN10, 2013 | 46 | 2013 |
| Activation of Nrf2/Keap1 pathway by oral Dimethylfumarate administration alleviates oxidative stress and age-associated infertility might be delayed in the mouse ovary N Akino, O Wada-Hiraike, W Isono, H Terao, H Honjo, Y Miyamoto, ... Reproductive Biology and Endocrinology 17, 1-10, 2019 | 41 | 2019 |
| Autophagy inhibition augments resveratrol‑induced apoptosis in Ishikawa endometrial cancer cells T Fukuda, K Oda, O Wada‑Hiraike, K Sone, K Inaba, Y Ikeda, C Makii, ... Oncology letters 12 (4), 2560-2566, 2016 | 41 | 2016 |
| MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53 C Makii, K Oda, Y Ikeda, K Sone, K Hasegawa, Y Uehara, A Nishijima, ... Oncotarget 7 (46), 75328, 2016 | 37 | 2016 |
| Application of artificial intelligence in gynecologic malignancies: A review K Sone, Y Toyohara, A Taguchi, Y Miyamoto, M Tanikawa, M Uchino‐Mori, ... Journal of Obstetrics and Gynaecology Research 47 (8), 2577-2585, 2021 | 36 | 2021 |
